AnaptysBio Inc (ANAB) is around the bottom of the Biotechnology industry according to InvestorsObserver. ANAB received an overall rating of 29, which means that it scores higher than 29 percent of all stocks. AnaptysBio Inc also achieved a score of 15 in the Biotechnology industry, putting it above 15 percent of Biotechnology stocks. Biotechnology is ranked 27 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 29 means the stock is more attractive than 29 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With AnaptysBio Inc Stock Today?
AnaptysBio Inc (ANAB) stock is up 6.94% while the S&P 500 is down -0.28% as of 10:40 AM on Monday, Oct 19. ANAB has risen $1.67 from the previous closing price of $24.08 on volume of 86,601 shares. Over the past year the S&P 500 has risen 15.54% while ANAB is down -29.87%. ANAB lost -$2.99 per share the over the last 12 months.
Click Here to get the full Stock Score Report on AnaptysBio Inc (ANAB) Stock.
